Relmada is a Florida-based biotechnology company that develops and commercializes novel therapies for the treatment of central nervous system disorders... Read more
Relmada is a Florida-based biotechnology company that develops and commercializes novel therapies for the treatment of central nervous system disorders... Read more
News
Mar 30, 2026
Seeking Alpha
Relmada Therapeutics: Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See
Mar 20, 2026
Nasdaq
Relmada Therapeutics: Relmada Posts Narrower FY25 Loss, Advances NVD-01 Toward Phase 3 In Bladder Cancer
Mar 20, 2026
Owler
Relmada Therapeutics, Inc.: Relmada Therapeutics's employee count had no change from Dec 2024 to Dec 2025
Mar 20, 2026
Seeking Alpha
Relmada Therapeutics: Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call Transcript
Mar 12, 2026
Zacks
Relmada Therapeutics: RLMD Stock Surges 42% in a Week: Here's What You Should Know
Mar 10, 2026
Yahoo
Relmada Therapeutics: A Look At Relmada Therapeutics (RLMD) Valuation After NDV-01 Phase 2 Update And US$160 Million Private Placement
Mar 09, 2026
Benzinga
Relmada Therapeutics: Relmada Therapeutics Stock Soaring Monday
Mar 09, 2026
Yahoo
Relmada Therapeutics: Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference
Mar 09, 2026
RTTNews
Relmada Therapeutics: Relmada Shares Surge On Positive Trial Data And $160M Financing
Jan 14, 2026
Indian Pharma Post
Relmada Therapeutics: FDA endorses Relmada's registrational strategy for bladder cancer therapy
Relmada Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10